| A10BD16 |
A10BD16 metformin and canagliflozin |
| A10BD17 |
A10BD17 metformin and acarbose |
| A10BD18 |
A10BD18 metformin and gemigliptin |
| A10BD19 |
A10BD19 linagliptin and empagliflozin |
| A10BD20 |
A10BD20 Metformin and empagliflozin |
| A10BD21 |
A10BD21 saxagliptin and dapagliflozin |
| A10BD22 |
A10BD22 Metformin And Evogliptin |
| A10BD23 |
A10BD23 Metformin and ertugliflozin |
| A10BD24 |
A10BD24 sitagliptin and ertugliflozin |
| A10BD25 |
A10BD25 Metformin, saxagliptin and dapagliflozin |
| A10BF |
A10BF Alpha glucosidase inhibitors |
| A10BF01 |
A10BF01 acarbose |
| A10BF02 |
A10BF02 miglitol |
| A10BF03 |
A10BF03 voglibose |
| A10BG |
A10BG Thiazolidinediones |
| A10BG01 |
A10BG01 troglitazone |
| A10BG02 |
A10BG02 rosiglitazone |
| A10BG03 |
A10BG03 pioglitazone |
| A10BH |
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| A10BH01 |
A10BH01 sitagliptin |
| A10BH02 |
A10BH02 vildagliptin |
| A10BH03 |
A10BH03 saxagliptin |
| A10BH04 |
A10BH04 alogliptin |
| A10BH05 |
A10BH05 linagliptin |
| A10BH06 |
A10BH06 gemigliptin |
| A10BH07 |
A10BH07 Evogliptin |
| A10BH08 |
A10BH08 Teneligliptin |
| A10BH51 |
A10BH51 Sitagliptin and Simvastatin |
| A10BH52 |
A10BH52 gemigliptin and rosuvastatin |
| A10BJ |
A10BJ Glucagon-like peptide-1 (GLP-1) analogues |